Comparative Clinical Outcomes of Patients with Low and Preserved Left Ventricular Ejection Fraction Undergoing Off-Pump Coronary Artery Bypass Surgery – A Single-Center Study


PDF PDF

Keywords

Off-pump coronary artery bypass grafting
left ventricular ejection fraction
myocardial dysfunction
cardiac surgery outcomes

How to Cite

1.
Comparative Clinical Outcomes of Patients with Low and Preserved Left Ventricular Ejection Fraction Undergoing Off-Pump Coronary Artery Bypass Surgery – A Single-Center Study. The Insight [Internet]. 2025 Nov. 28 [cited 2025 Nov. 28];8(03):466-70. Available from: https://bdjournals.org/insight/article/view/789

Abstract

Background: Left ventricular dysfunction is a major risk factor influencing outcomes after coronary artery bypass grafting (CABG). Off-pump CABG (OPCABG) has been proposed as a safer alternative for patients with reduced ejection fraction by avoiding cardiopulmonary bypass-related complications. This study aimed to compare intraoperative and early postoperative outcomes between patients with reduced and preserved left ventricular ejection fraction (LVEF). Methods & Materials: This comparative observational study was conducted in the Department of Cardiac surgery, United Hospital, Dhaka, Bangladesh, from July 2024 to December 2024. A total of 100 patients undergoing OPCABG were included: Group A (LVEF ≤35%, n=50) and Group B (LVEF >35%, n=50). Results: Patients with reduced LVEF were slightly older (61.8 ± 8.2 vs. 58.4 ± 7.9 years; p=0.041) and had more prior myocardial infarctions (64% vs. 44%; p=0.047). Group A received fewer grafts (2.7 ± 0.8 vs. 3.1 ± 0.7; p=0.008) and required longer operative time (220 ± 35 vs. 205 ± 30 min; p=0.03). The need for intra-aortic balloon pump (16% vs. 4%; p=0.046), prolonged inotropic support (42% vs. 20%; p=0.018), ICU stay (3.8 ± 1.6 vs. 2.9 ± 1.1 days; p=0.004), and hospital stay (9.2 ± 2.5 vs. 7.8 ± 2.0 days; p=0.006) were higher in Group A. LVEF improved significantly in both groups, with greater recovery in Group A (Δ% +8.4 ± 4.1 vs. +4.8 ± 3.9; p=0.002). Conclusion: OPCABG is safe and effective even in patients with severe left ventricular dysfunction, resulting in significant improvement in ventricular function and acceptable early morbidity and mortality rates.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 The Insight